1 Study Coverage 1.1 Osteoarthritis Therapeutics Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Introduction 1.2 Global Osteoarthritis Therapeutics Outlook 2017 VS 2022 VS 2028 1.2.1 Global Osteoarthritis Therapeutics Market Size for the Year 2017-2028 1.2.2 Global Osteoarthritis Therapeutics Market Size for the Year 2017-2028 1.3 Osteoarthritis Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Osteoarthritis Therapeutics in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Osteoarthritis Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Osteoarthritis Therapeutics Market Dynamics 1.4.1 Osteoarthritis Therapeutics Industry Trends 1.4.2 Osteoarthritis Therapeutics Market Drivers 1.4.3 Osteoarthritis Therapeutics Market Challenges 1.4.4 Osteoarthritis Therapeutics Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Osteoarthritis Therapeutics by Type 2.1 Osteoarthritis Therapeutics Market Segment by Type 2.1.1 Oral 2.1.2 Injection 2.1.3 External 2.2 Global Osteoarthritis Therapeutics Market Size by Type (2017, 2022 & 2028) 2.3 Global Osteoarthritis Therapeutics Market Size by Type (2017-2028) 2.4 United States Osteoarthritis Therapeutics Market Size by Type (2017, 2022 & 2028) 2.5 United States Osteoarthritis Therapeutics Market Size by Type (2017-2028) 3 Osteoarthritis Therapeutics by Application 3.1 Osteoarthritis Therapeutics Market Segment by Application 3.1.1 Medical Care 3.1.2 Personal Care 3.2 Global Osteoarthritis Therapeutics Market Size by Application (2017, 2022 & 2028) 3.3 Global Osteoarthritis Therapeutics Market Size by Application (2017-2028) 3.4 United States Osteoarthritis Therapeutics Market Size by Application (2017, 2022 & 2028) 3.5 United States Osteoarthritis Therapeutics Market Size by Application (2017-2028) 4 Global Osteoarthritis Therapeutics Competitor Landscape by Company 4.1 Global Osteoarthritis Therapeutics Market Size by Company 4.1.1 Top Global Osteoarthritis Therapeutics Companies Ranked by Revenue (2021) 4.1.2 Global Osteoarthritis Therapeutics Revenue by Player (2017-2022) 4.2 Global Osteoarthritis Therapeutics Concentration Ratio (CR) 4.2.1 Osteoarthritis Therapeutics Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Osteoarthritis Therapeutics in 2021 4.2.3 Global Osteoarthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Osteoarthritis Therapeutics Headquarters, Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Type 4.3.1 Global Osteoarthritis Therapeutics Headquarters and Area Served 4.3.2 Global Osteoarthritis Therapeutics Companies Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Osteoarthritis Therapeutics Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Osteoarthritis Therapeutics Market Size by Company 4.5.1 Top Osteoarthritis Therapeutics Players in United States, Ranked by Revenue (2021) 4.5.2 United States Osteoarthritis Therapeutics Revenue by Players (2020, 2021 & 2022) 5 Global Osteoarthritis Therapeutics Market Size by Region 5.1 Global Osteoarthritis Therapeutics Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Osteoarthritis Therapeutics Market Size by Region (2017-2028) 5.2.1 Global Osteoarthritis Therapeutics Market Size by Region: 2017-2022 5.2.2 Global Osteoarthritis Therapeutics Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Osteoarthritis Therapeutics Market Size YoY Growth 2017-2028 6.1.2 North America Osteoarthritis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Osteoarthritis Therapeutics Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Osteoarthritis Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Osteoarthritis Therapeutics Market Size YoY Growth 2017-2028 6.3.2 Europe Osteoarthritis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Osteoarthritis Therapeutics Market Size YoY Growth 2017-2028 6.4.2 Latin America Osteoarthritis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Osteoarthritis Therapeutics Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Osteoarthritis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Pfizer 7.1.1 Pfizer Company Details 7.1.2 Pfizer Business Overview 7.1.3 Pfizer Osteoarthritis Therapeutics Introduction 7.1.4 Pfizer Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.1.5 Pfizer Recent Development 7.2 Johnson & Johnson 7.2.1 Johnson & Johnson Company Details 7.2.2 Johnson & Johnson Business Overview 7.2.3 Johnson & Johnson Osteoarthritis Therapeutics Introduction 7.2.4 Johnson & Johnson Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.2.5 Johnson & Johnson Recent Development 7.3 GlaxoSmithKline 7.3.1 GlaxoSmithKline Company Details 7.3.2 GlaxoSmithKline Business Overview 7.3.3 GlaxoSmithKline Osteoarthritis Therapeutics Introduction 7.3.4 GlaxoSmithKline Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.3.5 GlaxoSmithKline Recent Development 7.4 Bayer 7.4.1 Bayer Company Details 7.4.2 Bayer Business Overview 7.4.3 Bayer Osteoarthritis Therapeutics Introduction 7.4.4 Bayer Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.4.5 Bayer Recent Development 7.5 Eli Lilly 7.5.1 Eli Lilly Company Details 7.5.2 Eli Lilly Business Overview 7.5.3 Eli Lilly Osteoarthritis Therapeutics Introduction 7.5.4 Eli Lilly Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.5.5 Eli Lilly Recent Development 7.6 Novartis 7.6.1 Novartis Company Details 7.6.2 Novartis Business Overview 7.6.3 Novartis Osteoarthritis Therapeutics Introduction 7.6.4 Novartis Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.6.5 Novartis Recent Development 7.7 Sanofi 7.7.1 Sanofi Company Details 7.7.2 Sanofi Business Overview 7.7.3 Sanofi Osteoarthritis Therapeutics Introduction 7.7.4 Sanofi Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.7.5 Sanofi Recent Development 7.8 Horizon Pharma 7.8.1 Horizon Pharma Company Details 7.8.2 Horizon Pharma Business Overview 7.8.3 Horizon Pharma Osteoarthritis Therapeutics Introduction 7.8.4 Horizon Pharma Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.8.5 Horizon Pharma Recent Development 7.9 Abbott 7.9.1 Abbott Company Details 7.9.2 Abbott Business Overview 7.9.3 Abbott Osteoarthritis Therapeutics Introduction 7.9.4 Abbott Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.9.5 Abbott Recent Development 7.10 Mylan 7.10.1 Mylan Company Details 7.10.2 Mylan Business Overview 7.10.3 Mylan Osteoarthritis Therapeutics Introduction 7.10.4 Mylan Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.10.5 Mylan Recent Development 7.11 Daiichi Sankyo 7.11.1 Daiichi Sankyo Company Details 7.11.2 Daiichi Sankyo Business Overview 7.11.3 Daiichi Sankyo Osteoarthritis Therapeutics Introduction 7.11.4 Daiichi Sankyo Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.11.5 Daiichi Sankyo Recent Development 7.12 TEVA 7.12.1 TEVA Company Details 7.12.2 TEVA Business Overview 7.12.3 TEVA Osteoarthritis Therapeutics Introduction 7.12.4 TEVA Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.12.5 TEVA Recent Development 7.13 Almatica Pharma 7.13.1 Almatica Pharma Company Details 7.13.2 Almatica Pharma Business Overview 7.13.3 Almatica Pharma Osteoarthritis Therapeutics Introduction 7.13.4 Almatica Pharma Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.13.5 Almatica Pharma Recent Development 7.14 Astellas Pharma 7.14.1 Astellas Pharma Company Details 7.14.2 Astellas Pharma Business Overview 7.14.3 Astellas Pharma Osteoarthritis Therapeutics Introduction 7.14.4 Astellas Pharma Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.14.5 Astellas Pharma Recent Development 7.15 Tide Pharmaceutical 7.15.1 Tide Pharmaceutical Company Details 7.15.2 Tide Pharmaceutical Business Overview 7.15.3 Tide Pharmaceutical Osteoarthritis Therapeutics Introduction 7.15.4 Tide Pharmaceutical Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.15.5 Tide Pharmaceutical Recent Development 7.16 Iroko Pharmaceuticals 7.16.1 Iroko Pharmaceuticals Company Details 7.16.2 Iroko Pharmaceuticals Business Overview 7.16.3 Iroko Pharmaceuticals Osteoarthritis Therapeutics Introduction 7.16.4 Iroko Pharmaceuticals Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.16.5 Iroko Pharmaceuticals Recent Development 7.17 Hengrui Pharmaceutical 7.17.1 Hengrui Pharmaceutical Company Details 7.17.2 Hengrui Pharmaceutical Business Overview 7.17.3 Hengrui Pharmaceutical Osteoarthritis Therapeutics Introduction 7.17.4 Hengrui Pharmaceutical Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.17.5 Hengrui Pharmaceutical Recent Development 7.18 Abiogen Pharma 7.18.1 Abiogen Pharma Company Details 7.18.2 Abiogen Pharma Business Overview 7.18.3 Abiogen Pharma Osteoarthritis Therapeutics Introduction 7.18.4 Abiogen Pharma Revenue in Osteoarthritis Therapeutics Business (2017-2022) 7.18.5 Abiogen Pharma Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Osteoarthritis Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Osteoarthritis Therapeutics Market Trends Table 3. Osteoarthritis Therapeutics Market Drivers Table 4. Osteoarthritis Therapeutics Market Challenges Table 5. Osteoarthritis Therapeutics Market Restraints Table 6. Global Osteoarthritis Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Osteoarthritis Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Osteoarthritis Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Osteoarthritis Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Osteoarthritis Therapeutics Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Osteoarthritis Therapeutics Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Osteoarthritis Therapeutics Revenue Share by Player, 2017-2022 Table 13. Global Osteoarthritis Therapeutics Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Osteoarthritis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Therapeutics as of 2021) Table 15. Top Players of Osteoarthritis Therapeutics in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Osteoarthritis Therapeutics Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Osteoarthritis Therapeutics Players in United States Market, Ranking by Revenue (2021) Table 20. United States Osteoarthritis Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Osteoarthritis Therapeutics Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Osteoarthritis Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Osteoarthritis Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Osteoarthritis Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Osteoarthritis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Osteoarthritis Therapeutics Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Osteoarthritis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Osteoarthritis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Osteoarthritis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Pfizer Company Details Table 31. Pfizer Business Overview Table 32. Pfizer Osteoarthritis Therapeutics Product Table 33. Pfizer Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 34. Pfizer Recent Development Table 35. Johnson & Johnson Company Details Table 36. Johnson & Johnson Business Overview Table 37. Johnson & Johnson Osteoarthritis Therapeutics Product Table 38. Johnson & Johnson Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 39. Johnson & Johnson Recent Development Table 40. GlaxoSmithKline Company Details Table 41. GlaxoSmithKline Business Overview Table 42. GlaxoSmithKline Osteoarthritis Therapeutics Product Table 43. GlaxoSmithKline Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 44. GlaxoSmithKline Recent Development Table 45. Bayer Company Details Table 46. Bayer Business Overview Table 47. Bayer Osteoarthritis Therapeutics Product Table 48. Bayer Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 49. Bayer Recent Development Table 50. Eli Lilly Company Details Table 51. Eli Lilly Business Overview Table 52. Eli Lilly Osteoarthritis Therapeutics Product Table 53. Eli Lilly Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 54. Eli Lilly Recent Development Table 55. Novartis Company Details Table 56. Novartis Business Overview Table 57. Novartis Osteoarthritis Therapeutics Product Table 58. Novartis Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 59. Novartis Recent Development Table 60. Sanofi Company Details Table 61. Sanofi Business Overview Table 62. Sanofi Osteoarthritis Therapeutics Product Table 63. Sanofi Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 64. Sanofi Recent Development Table 65. Horizon Pharma Company Details Table 66. Horizon Pharma Business Overview Table 67. Horizon Pharma Osteoarthritis Therapeutics Product Table 68. Horizon Pharma Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 69. Horizon Pharma Recent Development Table 70. Abbott Company Details Table 71. Abbott Business Overview Table 72. Abbott Osteoarthritis Therapeutics Product Table 73. Abbott Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 74. Abbott Recent Development Table 75. Mylan Company Details Table 76. Mylan Business Overview Table 77. Mylan Osteoarthritis Therapeutics Product Table 78. Mylan Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 79. Mylan Recent Development Table 80. Daiichi Sankyo Company Details Table 81. Daiichi Sankyo Business Overview Table 82. Daiichi Sankyo Osteoarthritis Therapeutics Product Table 83. Daiichi Sankyo Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 84. Daiichi Sankyo Recent Development Table 85. TEVA Company Details Table 86. TEVA Business Overview Table 87. TEVA Osteoarthritis Therapeutics Product Table 88. TEVA Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 89. TEVA Recent Development Table 90. Almatica Pharma Company Details Table 91. Almatica Pharma Business Overview Table 92. Almatica Pharma Osteoarthritis Therapeutics Product Table 93. Almatica Pharma Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 94. Almatica Pharma Recent Development Table 95. Astellas Pharma Company Details Table 96. Astellas Pharma Business Overview Table 97. Astellas Pharma Osteoarthritis Therapeutics Product Table 98. Astellas Pharma Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 99. Astellas Pharma Recent Development Table 100. Tide Pharmaceutical Company Details Table 101. Tide Pharmaceutical Business Overview Table 102. Tide Pharmaceutical Osteoarthritis Therapeutics Product Table 103. Tide Pharmaceutical Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 104. Tide Pharmaceutical Recent Development Table 105. Iroko Pharmaceuticals Company Details Table 106. Iroko Pharmaceuticals Business Overview Table 107. Iroko Pharmaceuticals Osteoarthritis Therapeutics Product Table 108. Iroko Pharmaceuticals Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 109. Iroko Pharmaceuticals Recent Development Table 110. Hengrui Pharmaceutical Company Details Table 111. Hengrui Pharmaceutical Business Overview Table 112. Hengrui Pharmaceutical Osteoarthritis Therapeutics Product Table 113. Hengrui Pharmaceutical Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 114. Hengrui Pharmaceutical Recent Development Table 115. Abiogen Pharma Company Details Table 116. Abiogen Pharma Business Overview Table 117. Abiogen Pharma Osteoarthritis Therapeutics Product Table 118. Abiogen Pharma Revenue in Osteoarthritis Therapeutics Business (2017-2022) & (US$ Million) Table 119. Abiogen Pharma Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Osteoarthritis Therapeutics Product Picture Figure 2. Global Osteoarthritis Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Osteoarthritis Therapeutics Market Size 2017-2028 (US$ Million) Figure 4. United States Osteoarthritis Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Osteoarthritis Therapeutics Market Size 2017-2028 (US$ Million) Figure 6. United States Osteoarthritis Therapeutics Market Share in Global 2017-2028 Figure 7. Osteoarthritis Therapeutics Report Years Considered Figure 8. Product Picture of Oral Figure 9. Product Picture of Injection Figure 10. Product Picture of External Figure 11. Global Osteoarthritis Therapeutics Market Share by Type in 2022 & 2028 Figure 12. Global Osteoarthritis Therapeutics Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Osteoarthritis Therapeutics Market Share by Type (2017-2028) Figure 14. United States Osteoarthritis Therapeutics Market Share by Type in 2022 & 2028 Figure 15. United States Osteoarthritis Therapeutics Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Osteoarthritis Therapeutics Market Share by Type (2017-2028) Figure 17. Product Picture of Medical Care Figure 18. Product Picture of Personal Care Figure 19. Global Osteoarthritis Therapeutics Market Share by Application in 2022 & 2028 Figure 20. Global Osteoarthritis Therapeutics Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global Osteoarthritis Therapeutics Market Share by Application (2017-2028) Figure 22. United States Osteoarthritis Therapeutics Market Share by Application in 2022 & 2028 Figure 23. United States Osteoarthritis Therapeutics Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States Osteoarthritis Therapeutics Market Share by Application (2017-2028) Figure 25. North America Osteoarthritis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe Osteoarthritis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Osteoarthritis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America Osteoarthritis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Osteoarthritis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. U.A.E Osteoarthritis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Pfizer Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 54. Johnson & Johnson Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 55. GlaxoSmithKline Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 56. Bayer Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 57. Eli Lilly Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 58. Novartis Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 59. Sanofi Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 60. Horizon Pharma Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 61. Abbott Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 62. Mylan Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 63. Daiichi Sankyo Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 64. TEVA Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 65. Almatica Pharma Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 66. Astellas Pharma Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 67. Tide Pharmaceutical Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 68. Iroko Pharmaceuticals Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 69. Hengrui Pharmaceutical Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 70. Abiogen Pharma Revenue Growth Rate in Osteoarthritis Therapeutics Business (2017-2022) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Pfizer Johnson & Johnson GlaxoSmithKline Bayer Eli Lilly Novartis Sanofi Horizon Pharma Abbott Mylan Daiichi Sankyo TEVA Almatica Pharma Astellas Pharma Tide Pharmaceutical Iroko Pharmaceuticals Hengrui Pharmaceutical Abiogen Pharma